Reviewed by Michael Gill, B. Sc.
25 Ptsd Clinical Trials Near Me
Top Hospitals for Ptsd Clinical Trials
Image of Michael E. DeBakey VA Medical Center, Houston, TX in Texas.
Michael E. DeBakey VA Medical Center, Houston, TX
3Active Trials
12All Time Trials for Ptsd
2011First Ptsd Trial
Image of University of Manitoba in Manitoba.
University of Manitoba
2Active Trials
3All Time Trials for Ptsd
2017First Ptsd Trial
Top Cities for Ptsd Clinical Trials
Image of New York in New York.
New York
6Active Trials
NYU Langone HealthTop Active Site
Image of Houston in Texas.
5Active Trials
Michael E. DeBakey VA Medical Center, Houston, TXTop Active Site
Ptsd Clinical Trials by Phase of Trial
Phase < 1 Ptsd Clinical Trials
1Active Ptsd Clinical Trials
1Number of Unique Treatments
1Number of Active Locations
NeuroPace® RNS® System
Ptsd Clinical Trials by Age Group
< 18 Ptsd Clinical Trials
3Active Ptsd Clinical Trials
DEEP VReScreen systemPCIP for youth aged 6 to 11
Most Recent Ptsd Clinical Trials
Top Treatments for Ptsd Clinical Trials
Treatment Name
Active Ptsd Clinical Trials
All Time Trials for Ptsd
First Recorded Ptsd Trial
Magnetic Resonance Imaging
Active Stimulation
Recently Completed Studies with FDA Approved Treatments for Ptsd
NYU Langone Health

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 8th, 2021

Last Reviewed: October 20th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57. Review. Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14. Review. BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-71. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993 Jun;88(6):791-804. Raes F, Pommier E, Neff KD, Van Gucht D. Construction and factorial validation of a short form of the Self-Compassion Scale. Clin Psychol Psychother. 2011 May-Jun;18(3):250-5. doi: 10.1002/cpp.702. Epub 2010 Jun 8. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6.